Natl Infusion Center v. Kennedy

25-50661

May 20, 2026
DOJ, Drugmakers Spar After Justices Snub 6 Negotiation Suits

The U.S. Department of Justice is trying to have it both ways in drug pricing litigation, telling the U.S. Supreme Court not to intervene before additional circuits decide pending challenges and then using this week's nonintervention as ammunition against those challenges, drugmakers are arguing at appeals courts.
April 04, 2026
Case-By-Case Guide As Justices Eye Landmark Pharma Law

Drugmakers and prominent allies are inundating the U.S. Supreme Court with calls to scrutinize Medicare's new power to slash payments by tens of billions of dollars, and the justices look poised to take up or turn down a fistful of legal challenges in one fell swoop.
January 12, 2026
The Curious, Very Long Delay In A Pioneering Drug Prices Suit

When Merck & Co. launched a fiery challenge to Medicare's landmark drug price negotiations, it blazed a trail for many similar suits. But 31 months later, the challenge is stalled where it started as Merck begs for a ruling, other suits speed along the path it created and huge costs now seem unavoidable.
October 07, 2025
Drug Tax Outdoes Biblical Punishment, 5th Circ. Judge Says

A Fifth Circuit panel pressed the U.S. Department of Health and Human Services to justify the basis for the Medicare drug pricing program's steep excise tax, asking Tuesday whether the government had ever levied a higher tax in the nation's history.

US Coverage